(Q34009185)

30 July 2017

1 reference

title

Primary cancer prevention trials (English)

1 reference

30 July 2017

Hawk ET

1

1 reference

30 July 2017

Lippman SM

series ordinal

2

1 reference

30 July 2017

publication date

1 August 2000

1 reference

Hematology / Oncology Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

14

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

809-830

1 reference

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Physical activity and reduced risk of colon cancer: implications for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Rationale and mechanisms of cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Low-dose aspirin and incidence of colorectal tumors in a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Selective cyclooxygenase-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Lipid-lowering therapy for the primary prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Powerful tools for genetic analysis come of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Update on aspirin in the treatment and prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Lessons from hypertension trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Validity versus generalizability in clinical trial design and conduct.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Recent advances in chemoprevention of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Immunoprevention of cancer poses a challenge to pharmacological research

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Tamoxifen prevention of breast cancer: an instance of the fingerpost

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Biomarkers as intermediate end points in chemoprevention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Cancer chemoprevention: progress and promise

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Efficacy of interventions designed to inhibit the progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

The late-stage diagnosis of colorectal cancer: demographic and socioeconomic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

The primary prevention of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps. Toronto Polyp Prevention Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Principles of human chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Experimental pathology and breast cancer genetics: new technologies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Co-carcinogenic effect of beta-carotene.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Effects of Long-term Sulindac Therapy on Colonic Polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Nutritional factors in cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Effects of health insurance and race on early detection of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Validation of intermediate end points in cancer research

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Laser-capture microdissection: opening the microscopic frontier to molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Colorectal cancer and nonsteroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

The war on cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Are surrogate markers adequate to assess cardiovascular disease drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

1 reference

7 January 2021

Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

An overview of chemoprevention: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Selective estrogen receptor modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970313-0

7 January 2021

10.1016/S0889-8588(05)70313-0

Identifiers

DOI

1 reference

30 July 2017

1 reference